Trial
NCT02657356
Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Biogen
Collaborators
—
Condition
Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
Intervention
Placebo capsules
Why stopped
Exposure of these high-risk patients to clinic or in-person visits during the pandemic presented an unacceptable risk to their health
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-06-04